Business

Critique of Barron’s Top 30 CEO Cover Story

Barron's has run a Top 30 CEO list and 21 of the 30 are returnees to the list, but there are many on this list that either are 1) questionable ...
Read Full Story »

Cramer’s Break-Up Plays

On today's STOP TRADING on CNBC, Cramer also said he thought the ads against Wal-Mart (WMT) on the terrorism link were too much.On Vonage (VG), after the ruling went against ...
Read Full Story »

Cramer Took the Pepsi Challenge

On today's WALL STREET CONFIDENTIAL video on TheStreet.com, Jim Cramer discussed going to the Pepsi (PEP) plant of the healthy snacks for Frito-Lay.  Cramer said he was critical of the ...
Read Full Story »

Wal-Mart: New Criticism Gone Too Far?

Before reading some non-stock and non-equity information, there of course is some stock-related data for you at the end of this article.After doing some routine outlying web searches this morning ...
Read Full Story »

Dendreon Interest Remains; Volume Already Beat Average Day

Dendreon (DNDN-NASDAQ) is still getting plenty of trader attention this morning.  It is going to post significantly higher volume than normal today as the chat rooms and message boards are ...
Read Full Story »

Can Amgen Get the Gorilla Off Its Neck?

Shares of biotech giant Amgen (AMGN) fell another 4% last night after the company announced more negative news.  The company is abandoning a clinical trial of Vectibix, its "was-promising" colon ...
Read Full Story »

Citigroup & ABN AMRO? The Chuck Prince Conundrum

There are multiple reports that Citigroup (C-NYSE) may have a faction inside the company pushing Chuck Prince to jump into the bidding process for ABN AMRO (ABN-NYSE/ADR).  This would be ...
Read Full Story »

Media Digest 3/23/2007

According to Reuters, Blackstone Group has filed to go public and raise $4 billion.Reuters writes that Carlyle, the private equity company, has raised a new fund worth $15 billion.Reuters reports ...
Read Full Story »

Thursday’s Top Biotech & Medical Stocks

From BioHealth Investorby H.S. AyoubBioHealth Investor.comBiotechnologyOSIRIS THERAPEUTICS [OSIR] +15.40% REXAHN PHARMACEUTICL [RXHN.OB] +12.90% ADVENTRX PHARMACTL [ANX] +10.05% MEDICURE INC [MCU] +8.91% BIONOVO INC [BNVI.OB] +8.51% Diagnostic SubstancesRG GLBL LIFESTYLS [RGBL.OB] ...
Read Full Story »

Cramer’s SELL BLOCK (MAR 22, 2007)

On CNBC's MAD MONEY tonight, Cramer featured his SELL BLOCK where he gives his sell or hold calls.Cramer said on Blockbuster (BBI) that Icahn screwed up getting rid of Antioco ...
Read Full Story »

Cramer on Telecom

Cramer on tonight's MAD MONEY on CNBC was discussing the upcoming huge federal government telecom contract worth $20 Billion out of the federal government.  Some place this worth up to ...
Read Full Story »
Homer loves BUD

Budweiser the King of Beers, maybe its the King of Stocks?

From The Stock MastersAnheuser-Busch Companies, Inc. (NYSE:BUD) has been getting plenty of good attention lately including upgrades and being added to Warren Buffett's portfolio just before the start of the ...
Read Full Story »

Dendreon’s Stock Activity

Dendreon (DNDN-NASDAQ) started making a mystery move at the end of the day, but you have to look at its calendar to see why it moved.  It appears that the ...
Read Full Story »

Cramer Positive on Metals

On today's STOP TRADING segment on CNBC, Cramer noted General Mills (GIS-NYSE): he said the CEO is good and money in the bank.  Cramer said the cost of corn in ...
Read Full Story »

Starbucks’ Credibility Problem

After a little up-tick yesterday when Starbucks (SBUX) said it would add 10,000 stores over the next four years, and double revenue in five, the stock is moving back down ...
Read Full Story »